Until June, 2007 Dr. Dolphin was the CEO of the BC Innovation Council. He is an internationally-renowned scientist and entrepreneur, and is the creator of Visudyne™, the world's most widely used ophthalmic drug, which has saved the vision of more than 700,000 people. Visudyne™ is the lead product for QLT, Inc, where Dr. Dolphin served as Vice President of Technology Development.
Previous appointments include acting Vice President, Research and acting Dean of Science at UBC. Dr. Dolphin, Professor Emeritus, is the author and editor of 18 books on spectroscopy, chemistry and biochemistry, and has published over 400 research papers. He holds more than 160 patents in Canada and the United States. Dr. Dolphin is the recipient of numerous awards including, most recently, the 2005 Gerhard Herzberg Gold Medal for Science and Engineering. His honors include being named a Fellow of the Royal Society of Canada, a Fellow of the Canadian Institute of Chemistry, a Fellow of the Royal Society (London), a Guggenheim Fellow, and the Order of Canada 2006. Dr. Dolphin has been designated a Hero of Chemistry by the American Chemical Society. Dr. Dolphin is Chair, Genome BC, and a board member of CFI and the Michael Smith Foundation.